HomeTCON • NASDAQ
add
TRACON Pharmaceuticals Inc
Previous close
$2.29
Day range
$2.06 - $2.34
Year range
$1.59 - $41.00
Market cap
4.80M USD
Avg Volume
420.83K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 3.04M | — |
Operating expense | 1.14M | -41.54% |
Net income | 439.00K | 106.27% |
Net profit margin | 14.42 | — |
Earnings per share | 0.20 | 103.23% |
EBITDA | 410.00K | 107.04% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 8.56M | -50.87% |
Total assets | 10.10M | -48.10% |
Total liabilities | 10.91M | -59.00% |
Total equity | -809.00K | — |
Shares outstanding | 2.28M | — |
Price to book | -6.19 | — |
Return on assets | 10.43% | — |
Return on capital | -105.71% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | 439.00K | 106.27% |
Cash from operations | -522.00K | 88.78% |
Cash from investing | — | — |
Cash from financing | 1.32M | -73.23% |
Net change in cash | 802.00K | 178.47% |
Free cash flow | -657.62K | 70.48% |
About
Founded
2004
Website
Employees
17